Amprius Technologies (AMPX) Financials

$2.84 -0.15 (-4.87%)

Closing price 03:59 PM Eastern

Extended Trading

$2.84 0.00 (0.00%)

As of 07:55 PM Eastern

Annual Income Statements for Amprius Technologies

This table shows Amprius Technologies' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Net Income / (Loss) Attributable to Common Shareholders	-45	-37	-17	-9.90
Consolidated Net Income / (Loss)	-45	-37	-17	-9.90
Net Income / (Loss) Continuing Operations	-45	-37	-17	-9.90
Total Pre-Tax Income	-45	-37	-17	-9.90
Total Operating Income	-46	-39	-18	-11
Total Gross Profit	-18	-15	-5.65	-4.33
Total Revenue	24	9.05	4.41	2.77
Operating Revenue	24	9.05	4.41	2.77
Total Cost of Revenue	42	24	10	7.10
Operating Cost of Revenue	42	24	10	7.10
Total Operating Expenses	28	24	12	6.29
Selling, General & Admin Expense	19	20	10	4.84
Research & Development Expense	7.34	3.68	2.03	1.45
Other Special Charges / (Income)	1.86	0.00	-	-
Total Other Income / (Expense), net	1.59	1.93	0.71	0.73
Interest & Investment Income	1.59	2.51	0.71	-0.02
Other Income / (Expense), net	0.00	-0.58	-	-
Basic Earnings per Share	($0.45)	($0.43)	($0.24)	($0.15)
Weighted Average Basic Shares Outstanding	101.87M	86.20M	71.34M	65.76M
Diluted Earnings per Share	($0.45)	($0.43)	($0.24)	($0.15)
Weighted Average Diluted Shares Outstanding	101.87M	86.20M	71.34M	65.76M
Weighted Average Basic & Diluted Shares Outstanding	117.93M	91.60M	84.63M	-

This table shows Amprius Technologies' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-11	-11	-13	-9.89	-9.73	-8.49	-9.45	-9.10	-6.06	-4.24
Consolidated Net Income / (Loss)	-11	-11	-13	-9.89	-9.73	-8.49	-9.45	-9.10	-6.06	-4.24
Net Income / (Loss) Continuing Operations	-11	-11	-13	-9.89	-9.73	-8.49	-9.45	-9.10	-6.06	-4.24
Total Pre-Tax Income	-11	-11	-13	-9.89	-9.73	-8.49	-9.45	-9.10	-6.06	-4.24
Total Operating Income	-12	-11	-13	-10	-9.74	-9.13	-10	-9.75	-6.65	-4.32
Total Gross Profit	-2.25	-5.10	-6.53	-4.45	-3.88	-4.25	-3.03	-3.52	-1.74	-1.51
Total Revenue	11	7.86	3.35	2.34	3.94	2.80	1.63	0.68	0.79	0.82
Operating Revenue	11	7.86	3.35	2.34	3.94	2.80	1.63	0.68	0.79	0.82
Total Cost of Revenue	13	13	9.88	6.78	7.82	7.05	4.66	4.20	2.53	2.33
Operating Cost of Revenue	13	13	9.88	6.78	7.82	7.05	4.66	4.20	2.53	2.33
Total Operating Expenses	9.51	6.15	6.40	5.87	5.87	4.88	7.05	6.23	4.91	2.81
Selling, General & Admin Expense	5.36	4.34	4.74	4.29	4.58	4.07	6.28	5.43	4.22	2.32
Research & Development Expense	2.28	1.82	1.66	1.58	1.29	0.82	0.77	0.80	0.69	0.49
Total Other Income / (Expense), net	0.34	0.40	0.42	0.43	0.01	0.64	0.64	0.65	0.59	0.08
Basic Earnings per Share	($0.11)	($0.10)	($0.13)	($0.11)	($0.11)	($0.10)	($0.11)	($0.11)	($0.08)	($0.06)
Weighted Average Basic Shares Outstanding	101.87M	110.41M	97.05M	90.03M	86.20M	86.35M	85.22M	84.65M	71.34M	69.01M
Diluted Earnings per Share	($0.11)	($0.10)	($0.13)	($0.11)	($0.11)	($0.10)	($0.11)	($0.11)	($0.08)	($0.06)
Weighted Average Diluted Shares Outstanding	101.87M	110.41M	97.05M	90.03M	86.20M	86.35M	85.22M	84.65M	71.34M	69.01M
Weighted Average Basic & Diluted Shares Outstanding	117.93M	105.84M	111.05M	94.47M	91.60M	88.40M	86.27M	84.97M	84.63M	84.47M

This table details how cash moves in and out of Amprius Technologies' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Net Change in Cash & Equivalents	11	-24	58	11
Net Cash From Operating Activities	-33	-26	-14	-8.02
Net Cash From Continuing Operating Activities	-33	-26	-14	-8.02
Net Income / (Loss) Continuing Operations	-45	-37	-17	-9.90
Consolidated Net Income / (Loss)	-45	-37	-17	-9.90
Depreciation Expense	3.81	1.81	1.54	1.44
Amortization Expense	6.39	3.06	1.59	0.55
Non-Cash Adjustments To Reconcile Net Income	9.21	5.61	3.27	1.89
Changes in Operating Assets and Liabilities, net	-8.08	0.75	-2.94	-2.00
Net Cash From Investing Activities	-3.21	-18	-1.48	-0.61
Net Cash From Continuing Investing Activities	-3.21	-18	-1.48	-0.61
Purchase of Property, Plant & Equipment	-3.21	-18	-1.48	-0.61
Net Cash From Financing Activities	47	19	74	20
Net Cash From Continuing Financing Activities	47	19	74	20
Repurchase of Common Equity	-0.76	-0.60	-0.33	0.00
Issuance of Common Equity	33	19	78	0.00
Other Financing Activities, net	14	0.31	-3.93	20

This table details how cash moves in and out of Amprius Technologies' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	20	-11	7.40	-5.52	-7.64	-12	0.82	-5.51	-4.38	69
Net Cash From Operating Activities	-6.09	-9.53	-7.96	-9.78	-4.80	-8.68	-5.58	-6.49	-5.70	-2.69
Net Cash From Continuing Operating Activities	-6.09	-9.53	-7.96	-9.78	-4.80	-8.68	-5.58	-6.49	-5.70	-2.69
Net Income / (Loss) Continuing Operations	-11	-11	-13	-9.89	-9.73	-8.49	-9.45	-9.10	-6.06	-4.24
Consolidated Net Income / (Loss)	-11	-11	-13	-9.89	-9.73	-8.49	-9.45	-9.10	-6.06	-4.24
Depreciation Expense	0.89	0.86	1.04	1.02	0.49	0.46	0.44	0.42	0.40	0.39
Amortization Expense	1.29	5.10	-	0.00	1.18	1.48	0.07	0.34	-	0.33
Non-Cash Adjustments To Reconcile Net Income	4.30	-0.85	3.23	2.53	2.84	0.61	1.43	0.73	0.73	0.91
Changes in Operating Assets and Liabilities, net	-1.14	-3.80	0.30	-3.44	0.43	-2.74	1.93	1.13	-0.77	-0.09
Net Cash From Investing Activities	3.63	-1.33	-1.61	-3.90	-5.75	-8.93	-1.73	-1.14	-0.73	-0.55
Net Cash From Continuing Investing Activities	3.63	-1.33	-1.61	-3.90	-5.75	-8.93	-1.73	-1.14	-0.73	-0.55
Purchase of Property, Plant & Equipment	3.63	-1.33	-1.61	-3.90	-5.75	-8.93	-1.73	-1.14	-0.73	-0.55
Net Cash From Financing Activities	23	-0.54	17	8.16	2.92	6.00	8.13	2.12	2.05	72
Net Cash From Continuing Financing Activities	23	-0.54	17	8.16	2.92	6.00	8.13	2.12	2.05	72
Issuance of Common Equity	23	-	2.73	8.13	2.92	6.04	8.12	2.39	-	78
Other Financing Activities, net	0.01	-	14	0.03	0.20	0.11	0.00	0.00	2.35	-6.05

This table presents Amprius Technologies' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Total Assets	121	108	83	19
Total Current Assets	69	51	75	14
Cash & Equivalents	55	46	70	11
Accounts Receivable	5.58	1.27	0.69	0.26
Inventories, net	6.57	0.73	0.50	0.50
Prepaid Expenses	1.45	1.99	2.39	0.16
Other Current Assets	0.00	0.78	1.90	1.77
Plant, Property, & Equipment, net	17	22	4.24	4.21
Total Noncurrent Assets	35	35	3.76	0.14
Other Noncurrent Operating Assets	35	35	3.76	0.14
Total Liabilities & Shareholders' Equity	121	108	83	19
Total Liabilities	52	48	10	4.67
Total Current Liabilities	17	13	6.92	4.17
Accounts Payable	12	8.94	3.74	1.81
Current Deferred Revenue	1.64	3.43	2.66	2.36
Other Current Liabilities	3.32	1.09	0.52	0.00
Total Noncurrent Liabilities	34	34	3.22	0.50
Other Noncurrent Operating Liabilities	34	34	2.50	0.00
Commitments & Contingencies	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	69	60	73	14
Total Preferred & Common Equity	69	60	73	14
Preferred Stock	0.00	0.00	0.00	-
Total Common Equity	69	60	73	14
Common Stock	244	189	166	89
Retained Earnings	-174	-130	-93	-75

This table presents Amprius Technologies' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	104	113	105	87	87	84	87
Total Current Assets	45	53	46	61	71	70	78
Cash & Equivalents	35	46	39	53	65	64	74
Accounts Receivable	4.59	1.74	1.44	1.89	1.13	0.56	0.78
Inventories, net	2.66	1.53	0.86	0.49	0.50	0.85	0.50
Prepaid Expenses	2.64	2.17	3.35	2.74	1.48	1.84	2.32
Other Current Assets	0.00	1.16	0.93	2.89	2.58	2.48	0.41
Plant, Property, & Equipment, net	24	24	23	17	6.90	4.95	3.82
Total Noncurrent Assets	35	36	36	8.55	9.03	9.10	4.86
Other Noncurrent Operating Assets	35	36	36	8.55	9.03	9.10	4.86
Total Liabilities & Shareholders' Equity	104	113	105	87	87	84	87
Total Liabilities	48	48	45	21	20	17	11
Total Current Liabilities	13	13	9.76	14	12	8.88	6.14
Accounts Payable	9.13	7.76	5.42	9.23	7.74	4.69	4.82
Current Deferred Revenue	1.82	3.15	3.24	3.57	3.20	3.14	0.80
Other Current Liabilities	2.05	1.92	1.10	1.08	1.07	1.06	0.52
Total Noncurrent Liabilities	35	35	35	6.98	7.94	8.03	4.36
Other Noncurrent Operating Liabilities	35	35	35	6.87	7.00	7.13	2.58
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	56	65	60	66	67	67	76
Total Preferred & Common Equity	56	65	60	66	67	67	76
Preferred Stock	0.00	0.00	0.00	0.00	0.00	-	-
Total Common Equity	56	65	60	66	67	67	76
Common Stock	219	217	199	186	178	169	163
Retained Earnings	-163	-152	-140	-120	-111	-102	-87

This table displays calculated financial ratios and metrics derived from Amprius Technologies' official financial filings.

Metric	2024	2023	2022	2021
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Growth Metrics	-	-	-	-
Revenue Growth	166.95%	105.33%	59.05%	0.00%
EBITDA Growth	-4.76%	-130.79%	-72.77%	0.00%
EBIT Growth	-17.75%	-117.78%	-69.83%	0.00%
NOPAT Growth	-19.51%	-114.56%	-69.83%	0.00%
Net Income Growth	-21.47%	-112.19%	-75.14%	0.00%
EPS Growth	-4.65%	-79.17%	-60.00%	0.00%
Operating Cash Flow Growth	-30.52%	-84.07%	-73.18%	0.00%
Free Cash Flow Firm Growth	13.59%	-178.00%	0.00%	0.00%
Invested Capital Growth	1.98%	320.71%	40.86%	0.00%
Revenue Q/Q Growth	38.26%	53.41%	0.00%	0.00%
EBITDA Q/Q Growth	-4.34%	-7.54%	0.00%	0.00%
EBIT Q/Q Growth	-4.55%	-10.33%	0.00%	0.00%
NOPAT Q/Q Growth	-4.55%	-8.70%	0.00%	0.00%
Net Income Q/Q Growth	-3.92%	-11.11%	0.00%	0.00%
EPS Q/Q Growth	0.00%	-7.50%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	-4.01%	3.40%	-40.32%	0.00%
Free Cash Flow Firm Q/Q Growth	17.45%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	-31.67%	13.58%	0.00%	0.00%
Profitability Metrics	-	-	-	-
Gross Margin	-75.85%	-162.11%	-128.24%	-156.17%
EBITDA Margin	-149.23%	-380.28%	-338.33%	-311.47%
Operating Margin	-191.43%	-427.58%	-409.19%	-383.23%
EBIT Margin	-191.43%	-434.00%	-409.19%	-383.23%
Profit (Net Income) Margin	-184.84%	-406.23%	-393.11%	-357.00%
Tax Burden Percent	100.00%	100.00%	100.00%	100.00%
Interest Burden Percent	96.56%	93.60%	96.07%	93.16%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-228.41%	-311.88%	-442.65%	-313.89%
ROIC Less NNEP Spread (ROIC-NNEP)	-204.05%	-295.11%	-431.06%	-292.48%
Return on Net Nonoperating Assets (RNNOA)	159.29%	256.51%	402.75%	242.48%
Return on Equity (ROE)	-69.11%	-55.37%	-39.89%	-71.41%
Cash Return on Invested Capital (CROIC)	-230.37%	-435.06%	-476.58%	0.00%
Operating Return on Assets (OROA)	-40.43%	-41.16%	-35.48%	-57.34%
Return on Assets (ROA)	-39.04%	-38.53%	-34.09%	-53.41%
Return on Common Equity (ROCE)	-69.11%	-55.37%	-39.89%	-71.41%
Return on Equity Simple (ROE_SIMPLE)	-64.30%	-61.50%	-23.73%	-71.41%
Net Operating Profit after Tax (NOPAT)	-32	-27	-13	-7.44
NOPAT Margin	-134.00%	-299.31%	-286.43%	-268.26%
Net Nonoperating Expense Percent (NNEP)	-24.35%	-16.77%	-11.59%	-21.41%
Return On Investment Capital (ROIC_SIMPLE)	-46.61%	-45.31%	-	-
Cost of Revenue to Revenue	175.85%	262.11%	228.24%	256.17%
SG&A Expenses to Revenue	77.49%	224.85%	234.97%	174.75%
R&D to Revenue	30.39%	40.62%	45.97%	52.31%
Operating Expenses to Revenue	115.58%	265.47%	280.95%	227.06%
Earnings before Interest and Taxes (EBIT)	-46	-39	-18	-11
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-36	-34	-15	-8.63
Valuation Ratios	-	-	-	-
Price to Book Value (P/BV)	4.27	7.82	9.17	14.43
Price to Tangible Book Value (P/TBV)	4.27	7.82	9.17	14.43
Price to Revenue (P/Rev)	12.26	51.65	151.92	72.15
Price to Earnings (P/E)	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	16.85	30.05	179.84	79.57
Enterprise Value to Revenue (EV/Rev)	9.98	46.60	136.12	68.01
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00
Financial Leverage	-0.78	-0.87	-0.93	-0.83
Leverage Ratio	1.77	1.44	1.17	1.34
Compound Leverage Factor	1.71	1.35	1.12	1.25
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00
Altman Z-Score	0.88	3.46	38.40	18.91
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-
Current Ratio	4.00	3.75	10.87	3.40
Quick Ratio	3.53	3.49	10.18	2.82
Cash Flow Metrics	-	-	-	-
Free Cash Flow to Firm (FCFF)	-33	-38	-14	0.00
Operating Cash Flow to CapEx	-1,039.98%	-145.60%	-937.34%	-1,316.26%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-
Asset Turnover	0.21	0.09	0.09	0.15
Accounts Receivable Turnover	7.06	9.28	9.30	10.58
Inventory Turnover	11.64	38.58	20.13	14.20
Fixed Asset Turnover	1.23	0.70	1.04	0.66
Accounts Payable Turnover	4.01	3.75	3.63	3.93
Days Sales Outstanding (DSO)	51.69	39.33	39.24	34.50
Days Inventory Outstanding (DIO)	31.37	9.46	18.14	25.70
Days Payable Outstanding (DPO)	91.00	97.45	100.49	92.78
Cash Conversion Cycle (CCC)	-7.95	-48.66	-43.11	-32.58
Capital & Investment Metrics	-	-	-	-
Invested Capital	14	14	3.34	2.37
Invested Capital Turnover	1.70	1.04	1.55	1.17
Increase / (Decrease) in Invested Capital	0.28	11	0.97	0.00
Enterprise Value (EV)	241	422	600	189
Market Capitalization	296	468	670	200
Book Value per Share	$0.66	$0.68	$0.86	$0.21
Tangible Book Value per Share	$0.66	$0.68	$0.86	$0.21
Total Capital	69	60	73	14
Total Debt	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00
Net Debt	-55	-46	-70	-11
Capital Expenditures (CapEx)	3.21	18	1.48	0.61
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-3.60	-8.70	-1.44	-1.48
Debt-free Net Working Capital (DFNWC)	52	37	68	10
Net Working Capital (NWC)	52	37	68	10
Net Nonoperating Expense (NNE)	12	9.68	4.70	2.46
Net Nonoperating Obligations (NNO)	-55	-46	-70	-11
Total Depreciation and Amortization (D&A)	10	4.86	3.12	1.99
Debt-free, Cash-free Net Working Capital to Revenue	-14.90%	-96.06%	-32.66%	-53.43%
Debt-free Net Working Capital to Revenue	213.32%	409.42%	1,548.11%	361.04%
Net Working Capital to Revenue	213.32%	409.42%	1,548.11%	361.04%
Earnings Adjustments	-	-	-	-
Adjusted Basic Earnings per Share	($0.45)	($0.43)	($0.24)	$0.00
Adjusted Weighted Average Basic Shares Outstanding	101.87M	86.20M	71.34M	0.00
Adjusted Diluted Earnings per Share	($0.45)	($0.43)	($0.24)	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	101.87M	86.20M	71.34M	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	117.93M	91.60M	84.63M	0.00
Normalized Net Operating Profit after Tax (NOPAT)	-31	-27	-13	-7.44
Normalized NOPAT Margin	-128.61%	-299.31%	-286.43%	-268.26%
Pre Tax Income Margin	-184.84%	-406.23%	-393.11%	-357.00%
Debt Service Ratios	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-1.69%	-1.63%	-1.88%	0.00%

This table displays calculated financial ratios and metrics derived from Amprius Technologies' official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	169.55%	180.74%	104.96%	244.04%	397.98%	242.89%	136.18%	-67.82%	0.00%	147.27%
EBITDA Growth	-18.58%	26.48%	-24.21%	-3.37%	-29.32%	-99.83%	-153.96%	-592.23%	0.00%	-14.70%
EBIT Growth	-20.67%	-23.24%	-28.26%	-5.83%	-46.59%	-111.22%	-142.32%	-235.09%	0.00%	-37.81%
NOPAT Growth	-20.67%	-23.24%	-28.26%	-5.83%	-46.59%	-111.22%	-142.32%	-235.09%	0.00%	-37.81%
Net Income Growth	-17.30%	-27.77%	-32.48%	-8.61%	-60.73%	-100.09%	-127.44%	-216.26%	0.00%	-35.12%
EPS Growth	0.00%	0.00%	-18.18%	0.00%	-37.50%	-66.67%	-83.33%	-175.00%	0.00%	-20.00%
Operating Cash Flow Growth	-26.77%	-9.81%	-42.56%	-50.63%	15.76%	-222.36%	-127.97%	-113.34%	-233.41%	0.00%
Free Cash Flow Firm Growth	51.44%	0.49%	-112.94%	-112.85%	0.00%	-216.79%	0.00%	0.00%	0.00%	0.00%
Invested Capital Growth	1.98%	69.53%	1,012.02%	633.50%	320.71%	462.07%	-99.20%	-98.62%	0.00%	0.00%
Revenue Q/Q Growth	35.34%	134.83%	43.19%	-40.77%	40.96%	71.45%	140.35%	-14.27%	-2.94%	18.09%
EBITDA Q/Q Growth	-81.25%	55.56%	-27.89%	-27.97%	-12.38%	24.92%	-6.42%	-44.03%	-73.65%	4.59%
EBIT Q/Q Growth	-4.49%	12.98%	-25.32%	-5.90%	-6.71%	9.44%	-3.40%	-46.70%	-53.76%	-3.89%
NOPAT Q/Q Growth	-4.49%	12.98%	-25.32%	-5.90%	-6.71%	9.44%	-3.40%	-46.70%	-53.76%	-3.89%
Net Income Q/Q Growth	-5.24%	13.32%	-26.61%	-1.56%	-14.63%	10.12%	-3.80%	-50.30%	-42.70%	-2.17%
EPS Q/Q Growth	-10.00%	23.08%	-18.18%	0.00%	-10.00%	9.09%	0.00%	-37.50%	-33.33%	0.00%
Operating Cash Flow Q/Q Growth	36.14%	-19.73%	18.61%	-103.73%	44.69%	-55.44%	14.00%	-13.93%	-111.66%	-9.92%
Free Cash Flow Firm Q/Q Growth	48.34%	36.78%	-3.12%	-44.19%	-5.86%	-108.22%	2.39%	0.00%	100.00%	0.00%
Invested Capital Q/Q Growth	-31.67%	12.16%	-10.57%	48.80%	13.58%	635.71%	-41.01%	-14.65%	51.75%	-98.95%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	-21.19%	-64.94%	-195.25%	-190.28%	-98.35%	-151.82%	-185.78%	-517.97%	-219.82%	-185.05%
EBITDA Margin	-90.12%	-67.29%	-355.64%	-398.20%	-204.87%	-256.97%	-586.83%	-1,325.33%	-788.89%	-440.93%
Operating Margin	-110.60%	-143.26%	-386.61%	-441.74%	-247.06%	-326.34%	-617.83%	-1,436.08%	-839.27%	-529.78%
EBIT Margin	-110.60%	-143.26%	-386.61%	-441.74%	-247.06%	-326.34%	-617.83%	-1,436.08%	-839.27%	-529.78%
Profit (Net Income) Margin	-107.40%	-138.13%	-374.20%	-423.20%	-246.81%	-303.50%	-578.92%	-1,340.50%	-764.65%	-520.10%
Tax Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Interest Burden Percent	97.11%	96.42%	96.79%	95.80%	99.90%	93.00%	93.70%	93.34%	91.11%	98.17%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-131.97%	-105.24%	-330.22%	-279.02%	-180.21%	-185.18%	-16.01%	-28.63%	-776.22%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-125.65%	-98.51%	-324.00%	-273.86%	-175.16%	-181.88%	-8.85%	-21.81%	-774.20%	0.00%
Return on Net Nonoperating Assets (RNNOA)	98.09%	71.56%	273.95%	222.66%	152.25%	163.20%	2.12%	5.28%	738.83%	0.00%
Return on Equity (ROE)	-33.88%	-33.68%	-56.27%	-56.36%	-27.96%	-21.98%	-13.89%	-23.34%	-37.39%	0.00%
Cash Return on Invested Capital (CROIC)	-230.37%	-237.54%	-456.64%	-383.65%	-435.06%	0.00%	0.00%	0.00%	-407.45%	0.00%
Operating Return on Assets (OROA)	-23.36%	-26.25%	-48.17%	-50.16%	-23.43%	-22.25%	-15.17%	-26.98%	-72.77%	0.00%
Return on Assets (ROA)	-22.68%	-25.31%	-46.63%	-48.06%	-23.41%	-20.69%	-14.21%	-25.19%	-66.30%	0.00%
Return on Common Equity (ROCE)	-33.88%	-33.68%	-56.27%	-56.36%	-27.96%	-21.98%	-2.41%	-3.89%	-37.39%	0.00%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-76.76%	-62.38%	-62.67%	0.00%	-50.33%	-43.26%	-35.14%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-8.23	-7.88	-9.05	-7.22	-6.82	-6.39	-7.06	-6.83	-4.65	-3.03
NOPAT Margin	-77.42%	-100.28%	-270.62%	-309.22%	-172.94%	-228.44%	-432.48%	-1,005.26%	-587.49%	-370.85%
Net Nonoperating Expense Percent (NNEP)	-6.32%	-6.72%	-6.22%	-5.16%	-5.05%	-3.30%	-7.16%	-6.81%	-2.01%	-3.30%
Return On Investment Capital (ROIC_SIMPLE)	-11.85%	-	-	-	-11.41%	-	-	-	-	-
Cost of Revenue to Revenue	121.19%	164.94%	295.25%	290.28%	198.35%	251.82%	285.78%	617.97%	319.82%	285.05%
SG&A Expenses to Revenue	50.41%	55.19%	141.67%	183.78%	116.00%	145.39%	384.74%	800.29%	532.32%	284.68%
R&D to Revenue	21.48%	23.13%	49.69%	67.68%	32.71%	29.13%	47.30%	117.82%	87.12%	60.05%
Operating Expenses to Revenue	89.41%	78.32%	191.36%	251.46%	148.71%	174.52%	432.05%	918.11%	619.44%	344.73%
Earnings before Interest and Taxes (EBIT)	-12	-11	-13	-10	-9.74	-9.13	-10	-9.75	-6.65	-4.32
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-9.58	-5.29	-12	-9.30	-8.08	-7.19	-9.58	-9.00	-6.25	-3.60
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.27	2.20	1.84	4.05	7.82	6.22	9.15	11.00	9.17	3.99
Price to Tangible Book Value (P/TBV)	4.27	2.20	1.84	4.05	7.82	6.22	9.15	11.00	9.17	3.99
Price to Revenue (P/Rev)	12.26	7.05	9.66	22.66	51.65	69.30	155.68	247.52	151.92	0.00
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	16.85	4.21	3.94	9.75	30.05	28.77	324.46	236.29	179.84	104.26
Enterprise Value to Revenue (EV/Rev)	9.98	5.05	5.92	19.02	46.60	60.25	139.09	225.97	136.12	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.78	-0.73	-0.85	-0.81	-0.87	-0.90	-0.24	-0.24	-0.95	-0.97
Leverage Ratio	1.77	1.57	1.51	1.49	1.44	1.22	1.15	1.15	1.17	1.14
Compound Leverage Factor	1.72	1.51	1.46	1.42	1.44	1.14	1.07	1.07	1.07	1.12
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	1.82	-0.48	-0.22	1.58	4.37	10.20	17.02	24.97	38.85	0.00
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	82.64%	83.33%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.00	3.46	4.14	4.67	3.75	4.42	5.89	7.87	10.87	12.68
Quick Ratio	3.53	3.05	3.76	4.15	3.49	3.98	5.51	7.29	10.18	12.16
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-8.51	-16	-26	-25	-18	-17	201	197	0.00	-5.23
Operating Cash Flow to CapEx	0.00%	-714.85%	-495.89%	-251.00%	-83.46%	-97.17%	-323.09%	-569.47%	-776.29%	-486.80%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.21	0.18	0.12	0.11	0.09	0.07	0.02	0.02	0.09	0.00
Accounts Receivable Turnover	7.06	5.40	8.66	10.73	9.28	4.42	0.00	0.00	9.30	0.00
Inventory Turnover	11.64	23.76	31.06	30.90	38.58	37.25	0.00	0.00	20.13	0.00
Fixed Asset Turnover	1.23	0.86	0.81	0.77	0.70	0.58	0.00	0.00	1.04	0.00
Accounts Payable Turnover	4.01	4.08	4.07	5.21	3.75	2.62	3.53	4.67	3.63	0.00
Days Sales Outstanding (DSO)	51.69	67.62	42.13	34.03	39.33	82.54	0.00	0.00	39.24	0.00
Days Inventory Outstanding (DIO)	31.37	15.36	11.75	11.81	9.46	9.80	0.00	0.00	18.14	0.00
Days Payable Outstanding (DPO)	91.00	89.49	89.71	70.12	97.45	139.07	103.33	78.18	100.49	0.00
Cash Conversion Cycle (CCC)	-7.95	-6.51	-35.83	-24.28	-48.66	-46.73	-103.33	-78.18	-43.11	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	14	21	19	21	14	12	1.68	2.85	3.34	2.20
Invested Capital Turnover	1.70	1.05	1.22	0.90	1.04	0.81	0.04	0.03	1.32	0.00
Increase / (Decrease) in Invested Capital	0.28	8.59	17	18	11	10	-208	-203	0.00	2.20
Enterprise Value (EV)	241	88	74	204	422	356	545	673	600	229
Market Capitalization	296	123	120	243	468	409	610	737	670	303
Book Value per Share	$0.66	$0.50	$0.69	$0.65	$0.68	$0.76	$0.78	$0.79	$0.86	$2.31
Tangible Book Value per Share	$0.66	$0.50	$0.69	$0.65	$0.68	$0.76	$0.78	$0.79	$0.86	$2.31
Total Capital	69	56	65	60	60	66	67	67	73	76
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-55	-35	-46	-39	-46	-53	-65	-64	-70	-74
Capital Expenditures (CapEx)	-3.63	1.33	1.61	3.90	5.75	8.93	1.73	1.14	0.73	0.55
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-3.60	-3.11	-6.23	-3.18	-8.70	-5.88	-6.32	-3.17	-1.44	-2.12
Debt-free Net Working Capital (DFNWC)	52	32	40	36	37	48	59	61	68	72
Net Working Capital (NWC)	52	32	40	36	37	48	59	61	68	72
Net Nonoperating Expense (NNE)	3.19	2.97	3.46	2.66	2.91	2.10	2.39	2.28	1.40	1.22
Net Nonoperating Obligations (NNO)	-55	-35	-46	-39	-46	-53	-65	-64	-70	-74
Total Depreciation and Amortization (D&A)	2.18	5.97	1.04	1.02	1.66	1.94	0.51	0.75	0.40	0.73
Debt-free, Cash-free Net Working Capital to Revenue	-14.90%	-17.76%	-50.15%	-29.73%	-96.06%	-99.59%	-161.16%	-106.38%	-32.66%	0.00%
Debt-free Net Working Capital to Revenue	213.32%	182.72%	323.73%	334.84%	409.42%	805.27%	1,497.68%	2,048.99%	1,548.11%	0.00%
Net Working Capital to Revenue	213.32%	182.72%	323.73%	334.84%	409.42%	805.27%	1,497.68%	2,048.99%	1,548.11%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.11)	($0.10)	($0.13)	($0.11)	($0.11)	($0.10)	($0.11)	($0.11)	($0.08)	($0.06)
Adjusted Weighted Average Basic Shares Outstanding	101.87M	110.41M	97.05M	90.03M	86.20M	86.35M	85.22M	84.65M	71.34M	69.01M
Adjusted Diluted Earnings per Share	($0.11)	($0.10)	($0.13)	($0.11)	($0.11)	($0.10)	($0.11)	($0.11)	($0.08)	($0.06)
Adjusted Weighted Average Diluted Shares Outstanding	101.87M	110.41M	97.05M	90.03M	86.20M	86.35M	85.22M	84.65M	71.34M	69.01M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	117.93M	105.84M	111.05M	94.47M	91.60M	88.40M	86.27M	84.97M	84.63M	84.47M
Normalized Net Operating Profit after Tax (NOPAT)	-8.23	-7.88	-9.05	-7.22	-6.82	-6.39	-7.06	-6.83	-4.65	-3.03
Normalized NOPAT Margin	-77.42%	-100.28%	-270.62%	-309.22%	-172.94%	-228.44%	-432.48%	-1,005.26%	-587.49%	-370.85%
Pre Tax Income Margin	-107.40%	-138.13%	-374.20%	-423.20%	-246.81%	-303.50%	-578.92%	-1,340.50%	-764.65%	-520.10%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-1.69%	-2.21%	-1.39%	-0.89%	-1.63%	-2.14%	-2.01%	-2.52%	-1.88%	0.00%

Frequently Asked Questions About Amprius Technologies' Financials

When does Amprius Technologies's fiscal year end?

According to the most recent income statement we have on file, Amprius Technologies' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Amprius Technologies' net income changed over the last 3 years?

Amprius Technologies' net income appears to be on an upward trend, with a most recent value of -$44.67 million in 2024, rising from -$9.90 million in 2021. The previous period was -$36.78 million in 2023. Find out what analysts predict for Amprius Technologies in the coming months.

What is Amprius Technologies's operating income?

Amprius Technologies's total operating income in 2024 was -$46.26 million, based on the following breakdown:

Total Gross Profit: -$18.33 million
Total Operating Expenses: $27.93 million

How has Amprius Technologies revenue changed over the last 3 years?

Over the last 3 years, Amprius Technologies' total revenue changed from $2.77 million in 2021 to $24.17 million in 2024, a change of 771.8%.

How much debt does Amprius Technologies have?

Amprius Technologies' total liabilities were at $51.65 million at the end of 2024, a 7.8% increase from 2023, and a 1,006.3% increase since 2021.

How much cash does Amprius Technologies have?

In the past 3 years, Amprius Technologies' cash and equivalents has ranged from $11.49 million in 2021 to $69.70 million in 2022, and is currently $55.16 million as of their latest financial filing in 2024.

How has Amprius Technologies' book value per share changed over the last 3 years?

Over the last 3 years, Amprius Technologies' book value per share changed from 0.21 in 2021 to 0.66 in 2024, a change of 211.5%.

Related Companies

This page (NYSE:AMPX) was last updated on 5/29/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Amprius Technologies (AMPX) Financials

Frequently Asked Questions About Amprius Technologies' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Amprius Technologies (AMPX) Financials

Annual Income Statements for Amprius Technologies

Quarterly Income Statements for Amprius Technologies

Annual Cash Flow Statements for Amprius Technologies

Quarterly Cash Flow Statements for Amprius Technologies

Annual Balance Sheets for Amprius Technologies

Quarterly Balance Sheets for Amprius Technologies

Annual Metrics And Ratios for Amprius Technologies

Quarterly Metrics And Ratios for Amprius Technologies

Frequently Asked Questions About Amprius Technologies' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools